4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-25-079822
Chief Medical Officer sold 3,932 shares at $35.94 ($141,316)
- Chief Medical Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Naimish Chief Medical Officer | 2025-05-28 | Option exercise | +10,000 | 10,000 | D | ||
| Patel Naimish Chief Medical Officer | 2025-05-29 | Sale | −3,932 | $35.94 | $141,316 | 6,068 | D |
| Derivatives | |||||||
| Patel Naimish Chief Medical Officer | 2025-05-28 | Option exercise · Restricted Stock Units | −10,000 | 30,000 | D | ||
| Open-market sales · 3,932 sh · avg $35.94 · $141,316 | |||||||
Loading xslF345X05/ownership.xml…